Assessment of Pharmacoeconomic Evaluations Submitted for Reimbursement in Korea
Authors:
- Sang Hee LimSLSang Hee Lim
- Mi-Jeong OhMOMi-Jeong Oh
- Hye Kyung ParkHPHye Kyung Park
- Ji-Ryoun GongJGJi-Ryoun Gong
- Sung Eun ParkSPSung Eun Park
- So Young YiSYSo Young Yi
- 1 January 2012
- journal article
- Published by Elsevier in Value in Health
- Vol. 15 (1) , S104-S110
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Pharmacoeconomic Guidelines and Their Implementation in the Positive List System in South KoreaValue in Health, 2009
- Optimizing the use of prescription drugs in Canada through the Common Drug ReviewCanadian Medical Association Journal, 2008
- The NICE Cost-Effectiveness ThresholdPharmacoEconomics, 2008
- Economic Evaluation and Decision Making in the UKPharmacoEconomics, 2006
- Introducing Economic Evaluation as a Policy Tool in Korea: Will Decision Makers get Quality Information?PharmacoEconomics, 2005
- Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?Value in Health, 2004
- National Institute for Clinical Excellence and its value judgmentsBMJ, 2004
- Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysisHealth Economics, 2004
- Cost-Effectiveness Analysis and the Consistency of Decision MakingPharmacoEconomics, 2001
- Using Economic Evaluations to Make Formulary Coverage DecisionsPharmacoEconomics, 2000